openPR Logo
Press release

Lung Cancer Diagnostics Market Expansion Driven by Liquid Biopsy Demand and Early Detection Initiatives 2025-2033 | F. Hoffmann-La Roche Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical

07-16-2025 01:39 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Lung Cancer Diagnostics Market

Lung Cancer Diagnostics Market

The global lung cancer diagnostics market reached US$ 4.94 billion in 2024 and is expected to reach US$ 8.44 billion by 2033, growing at a CAGR of 6.18% during the forecast period 2025-2033.

Lung Cancer Diagnostics Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-diagnostics-market?ophp

Lung cancer diagnostics include imaging, biomarker testing, and molecular diagnostics used for early detection and subtype classification. The market is expanding due to rising lung cancer prevalence, adoption of liquid biopsies and NGS, and the growing importance of companion diagnostics for targeted therapies.

Lung Cancer Diagnostics Market Competitors Overview:

Quest Diagnostics Incorporated, Biodesix, Lepu Medical Technology (Beijing)Co., Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical, bioAffinity Technologies, Inc., Optellum Ltd and F. Hoffmann-La Roche Ltd. among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In January 2025, Monitor Corporation has begun selling its lung cancer diagnosis software in Japan through a partnership with Doctor-NET, a Japanese digital healthcare provider.

Methodology and Scope

The Lung Cancer Diagnostics Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-cancer-diagnostics-market?ophp

Lung Cancer Diagnostics Market Segments Overview:

∎ By Type (Small Cell Lung Cancer (Small Cell Carcinoma, Combined Small Cell Carcinoma), Non-small Cell Lung Cancer (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Others)
∎ By Diagnosis (Imaging Tests, Sputum Cytology, Biopsy, Biomarker Testing, Others)
∎ By End User (Hospitals, Diagnostic Centers, Others)

Regional Overview for Lung Cancer Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=lung-cancer-diagnostics-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Diagnostics Market Expansion Driven by Liquid Biopsy Demand and Early Detection Initiatives 2025-2033 | F. Hoffmann-La Roche Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical here

News-ID: 4106439 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Polymyalgia Rheumatica Treatment Market Expands Due to Aging Population and Improved Clinical Recognition | F. Hoffmann-La Roche Ltd., Sanofi, Novartis AG, Regeneron Pharmaceuticals, Mylan N.V.
Polymyalgia Rheumatica Treatment Market Expands Due to Aging Population and Impr …
Polymyalgia Rheumatica Treatment Market reached US$ 3.35 Billion in 2024 and is expected to reach US$ 4.98 Billion by 2031, growing at a CAGR of 4.7% during the forecast period 2024-2031. Polymyalgia Rheumatica Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory
Optic Neuritis Treatment Market Supported by MS-Linked Prevalence and Innovations in Ophthalmic Imaging | Mallinckrodt Pharmaceuticals, Teijin Pharmaceutical Limited, AbbVie (Allergan PLC), AdvaCare Pharma, Novartis AG
Optic Neuritis Treatment Market Supported by MS-Linked Prevalence and Innovation …
Optic Neuritis Treatment Market reached US$ 204 million in 2022 and is expected to reach US$ 310 million by 2031, growing at a CAGR of 5.6% during the forecast period 2024-2031. Optic Neuritis Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory
Idiopathic Hypersomnia Treatment Market Propelled by Rising Sleep Disorder Diagnosis and Breakthrough CNS Therapies | Jazz Pharmaceuticals plc, Harmony Biosciences Holdings, Inc., AVADEL PHARMACEUTICALS PLC
Idiopathic Hypersomnia Treatment Market Propelled by Rising Sleep Disorder Diagn …
Global idiopathic hypersomnia treatment market reached USD 1.5 Billion in 2024 and is expected to reach US$ 2.8 Billion by 2031, growing at a CAGR of 9% during the forecast period 2024-2031. Idiopathic Hypersomnia Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms,
Cutaneous Lupus Erythematosus Market Gains Momentum with Advancements in Autoimmune Drug Development and Personalized Therapies | AstraZeneca, AbbVie Inc, ImmuPharma PLC, Biogen Inc, Eli Lilly and Company
Cutaneous Lupus Erythematosus Market Gains Momentum with Advancements in Autoimm …
Global Cutaneous Lupus Erythematosus Market reached USD 2.85 Billion in 2024 and is expected to reach USD 7.70 Billion by 2031, growing at a CAGR of 13% during the forecast period 2024-2031. Cutaneous Lupus Erythematosus Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Lung Cancer Surgery Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Lung Cancer Surgery Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the Lung Cancer Surgery Market. Increased demand for the technologies is also one of the factors, which are likely to boost the growth of this industry. The
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor